Vindesine is a Vinca alkaloid. This chemotherapy drug is administered intravenously and has a serum half-life of about 24 hours and is administered at a
dose of 3 milligrams per square meter of body surface. Its toxicity and side effects are similar to those of vinblastine. Vindesine, which is marketed
under trade names such as Eldisine and Fildesin, is used mainly to treat melanoma and
lung cancers (carcinomas) and, with other drugs, to treat uterine cancers.